Epsilon Healthcare Limited (ASX:EPN)
0.0320
-0.0010 (-3.03%)
Jan 30, 2026, 3:07 PM AEST
Epsilon Healthcare Company Description
Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia.
The company operates in two segments, Contract Development and Manufacturing Activities; and Telehealth Medical Practice Services.
It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulations; and provision of pharmacy services and patient care.
The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021.
Epsilon Healthcare Limited was incorporated in 2016 and is based in Southport, Australia.
Epsilon Healthcare Limited
| Country | Australia |
| Founded | 2016 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Peter Giannopoulos |
Contact Details
Address: 5 Goodyear Street Southport, QLD 4215 Australia | |
| Website | epsilonhealthcare.com.au |
Stock Details
| Ticker Symbol | EPN |
| Exchange | Australian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | AUD |
| ISIN Number | AU0000137598 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Peter Giannopoulos | Group Chief Executive Officer, MD and Executive Director |
| Daniel Kaplon | Chief Financial Officer and Company Secretary |
| Li Lin | Group Financial Controller |